Factors Influencing Lower Urinary Tract Symptoms in Advanced Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy.
- Author:
Ok Hee CHO
1
;
Yang Sook YOO
;
Joon Chul KIM
;
Ran Hee PARK
;
Kyung Hye HWANG
Author Information
- Publication Type:Original Article
- Keywords: Neoplasm metastasis; Patients; Peripheral neuropathy; Lower urinary tract symptomsy
- MeSH: Cross-Sectional Studies; Diagnosis; Humans; Lower Urinary Tract Symptoms*; Neoplasm Metastasis; Nocturia; Peripheral Nervous System Diseases*; Prostate
- From:International Neurourology Journal 2018;22(3):192-199
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: This study aimed to investigate the severity of lower urinary tract symptoms (LUTS) and to identify factors that influenced LUTS in advanced cancer patients with chemotherapy-induced peripheral neuropathy (CIPN). METHODS: This cross-sectional study included a total of 158 advanced cancer patients with CIPN. A structured questionnaire including the International Prostate Symptom Score and the Functional Assessment of Cancer Therapy/Gynecology Oncology Group/Neurotoxicity scale was used. Data were analyzed using the Pearson correlation coefficient and multiple regression analysis. RESULTS: Nocturia was the most prevalent LUTS. A positive relationship was found between CIPN symptoms and LUTS. The duration of cancer diagnosis and the severity of CIPN were key factors that influenced LUTS. CONCLUSIONS: The severity of CIPN symptoms was the most important predictor of LUTS. Nurses’ care for advanced cancer patients should incorporate a comprehensive health assessment, which includes a history of treatment and physical neuropathic symptoms, for any patient complaining of CIPN symptoms.
